SEC Form 3 · accession 0001209191-16-111299
Eiger BioPharmaceuticals, Inc. · EIGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Philip T Gianos
10% Owner · Other
Arnold L Oronsky
10% Owner · Other
Khaled Nasr
10% Owner · Other
Gilbert H Kliman
10% Owner · Other
W Stephen Holmes
10% Owner · Other
Bruce A Cleveland
10% Owner · Other
INTERWEST PARTNERS X LP
10% Owner
InterWest Management Partners X, LLC
10% Owner · Other
Keval Desai
10% Owner · Other
Period of report
Mar 22, 2016
Accepted (ET)
Mar 31, 2016 · 7:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001305253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,599,593 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are owned by InterWest Partners X, LP ("IW10"). InterWest Management Partners X, LLC ("IMP10") is the general partner of IW10. Bruce A. Cleveland, Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are managing directors of IMP10. Keval Desai and Khaled A. Nasr are venture members of IMP10. Each managing director and venture member of IMP10 disclaims beneficial ownership of such shares, except to the extent of his or her pecuniary interest therein.